RESUMO
Genetic variation arises through multiple different alleles that vary in frequency and severity of effect. Mutations that give rise to Mendelian disorders, such as the LDL receptor (LDLR) mutations that result in familial hypercholesterolaemia, are efficiently winnowed from the population by purifying selection and are almost inevitably rare. Conversely, alleles that are common in the population (such that homozygotes for the minor allele are present even in modest sample sizes) typically have very modest phenotypic effects. Mutations in the gene for proprotein convertase subtilisin/kexin type 9 (PCSK9) represent an unusual but informative exception in that they are relatively common but have large effects on phenotype. Loss-of-function mutations in PCSK9 occur in ~2.5% of African Americans and are associated with large reductions in coronary heart disease (CHD) risk. The development of agents to inhibit PCSK9 demonstrates the utility of translating genetics into clinical therapeutics. Attempts to identify genes responsible for hypercholesterolaemia have used traditional linkage analysis, which requires samples collected from multiple families with defects in the same gene, or genome-wide association, which requires thousands of samples from the population. More recently, whole-exome sequencing studies have revealed loss-of-function mutations in ANGPTL3 associated with pan-hypolipidemia, and in APOC3 that confer protection against CHD. The application of whole-exome sequencing to large populations or to carefully selected patients can streamline the discovery of causal genetic mutations.
Assuntos
Terapia Genética , Hiperlipoproteinemia Tipo II/genética , Hiperlipoproteinemia Tipo II/terapia , Animais , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Doença das Coronárias/sangue , Doença das Coronárias/genética , Doença das Coronárias/prevenção & controle , Doença das Coronárias/terapia , Humanos , Hiperlipoproteinemia Tipo II/sangue , Hiperlipoproteinemia Tipo II/prevenção & controle , Mutação , Pró-Proteína Convertase 9/genéticaRESUMO
Comparison of genomic DNA sequences from human and mouse revealed a new apolipoprotein (APO) gene (APOAV) located proximal to the well-characterized APOAI/CIII/AIV gene cluster on human 11q23. Mice expressing a human APOAV transgene showed a decrease in plasma triglyceride concentrations to one-third of those in control mice; conversely, knockout mice lacking Apoav had four times as much plasma triglycerides as controls. In humans, single nucleotide polymorphisms (SNPs) across the APOAV locus were found to be significantly associated with plasma triglyceride levels in two independent studies. These findings indicate that APOAV is an important determinant of plasma triglyceride levels, a major risk factor for coronary artery disease.
Assuntos
Apolipoproteínas/genética , Apolipoproteínas/fisiologia , Triglicerídeos/sangue , Adulto , Alelos , Animais , Apolipoproteína A-V , Apolipoproteína C-III , Apolipoproteínas A , Apolipoproteínas C/sangue , Cromossomos Humanos Par 11 , Estudos de Coortes , Biologia Computacional , Doença das Coronárias/etiologia , Doença das Coronárias/genética , Etiquetas de Sequências Expressas , Feminino , Haplótipos , Humanos , Desequilíbrio de Ligação , Lipoproteínas VLDL/sangue , Masculino , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Família Multigênica , Fases de Leitura Aberta , Polimorfismo de Nucleotídeo Único , Fatores de Risco , Análise de Sequência de DNA , TransgenesRESUMO
Atherogenic low density lipoproteins are cleared from the circulation by hepatic low density lipoprotein receptors (LDLR). Two inherited forms of hypercholesterolemia result from loss of LDLR activity: autosomal dominant familial hypercholesterolemia (FH), caused by mutations in the LDLR gene, and autosomal recessive hypercholesterolemia (ARH), of unknown etiology. Here we map the ARH locus to an approximately 1-centimorgan interval on chromosome 1p35 and identify six mutations in a gene encoding a putative adaptor protein (ARH). ARH contains a phosphotyrosine binding (PTB) domain, which in other proteins binds NPXY motifs in the cytoplasmic tails of cell-surface receptors, including the LDLR. ARH appears to have a tissue-specific role in LDLR function, as it is required in liver but not in fibroblasts.
Assuntos
Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Cromossomos Humanos Par 1/genética , Genes Recessivos/genética , Hipercolesterolemia/genética , Mutação/genética , Receptores de LDL/metabolismo , Adolescente , Adulto , Sequência de Aminoácidos , Sítios de Ligação , Proteínas de Transporte/química , Criança , Pré-Escolar , Mapeamento Cromossômico , Clonagem Molecular , Éxons/genética , Feminino , Fibroblastos , Homozigoto , Humanos , Hipercolesterolemia/metabolismo , Hipercolesterolemia/fisiopatologia , Íntrons/genética , Itália , Líbano , Fígado/metabolismo , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Especificidade de Órgãos , Linhagem , Fosfotirosina/metabolismo , Ligação Proteica , RNA Mensageiro/análise , RNA Mensageiro/genética , Alinhamento de Sequência , Técnicas do Sistema de Duplo-HíbridoRESUMO
BACKGROUND: Recently it has been asserted that a closed chamber evaporimeter, the VapoMeter, offers advantages over standard open chamber devices in measuring transepidermal water loss (TEWL). Purported improvements include the ability to take measurements at any angle, short reading times and insensitivity to external air currents. These claims are compelling, considering that measuring TEWL at diverse skin sites can be tedious, especially with children. The primary aim of this study was to compare the performance of closed and open chamber instruments when they were held at various angles and, secondly to evaluate the ability of the devices to discriminate between test conditions. METHODS: The performance of closed chamber (VapoMeter) and open chamber (DermaLab) evaporimeters were compared by measuring water vapor emitted from IMS Vitro-skin that had been hydrated to a predetermined level. Measurements were taken at three angles from vertical - 0 degrees, 45 degrees, and 90 degrees. Vitro-skin samples were weighed periodically throughout the experimental phase to verify water loss rates. RESULTS: Both the VapoMeter and the DermaLab yielded significantly lower water loss values when held at angles that varied from the vertical (0 degrees) position, indicating that the closed chamber device is no more capable of accurately measuring TEWL at any angle than an open chamber instrument. The DermaLab provided better discrimination than the VapoMeter when the instruments were held vertically, as is the only prescribed testing position for open-chamber instruments. The VapoMeter was easier to use than the DermaLab; however, there was evidence that the sealed chamber could become saturated under high water loss conditions. CONCLUSIONS: Previous assertions that the VapoMeter closed chamber evaporimeter is capable of measuring TEWL regardless of angle were not validated. Each device appeared capable of accurately estimating water loss rates only in the vertical position. Although the VapoMeter was easier to use than the open chamber device, its tendency to become saturated under high water loss conditions could be a disadvantage when assessing dynamic TEWL.
Assuntos
Água Corporal/metabolismo , Absorção Cutânea/fisiologia , Testes Cutâneos/instrumentação , Perda Insensível de Água/fisiologia , Água/análise , Desenho de Equipamento , Análise de Falha de Equipamento , Humanos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Testes Cutâneos/métodosRESUMO
Poor drug access continues to be one of the main global health problems. Global inequalities in access to pharmaceuticals are caused by a number of variables including poverty, high drug prices, poor health infrastructure, and fraud and corruption--the latter being the subject of this article. There is growing recognition among policy makers that corruption in the pharmaceutical system can waste valuable resources allocated to pharmaceutical products and services. This, in turn, denies those most in need from life-saving or life-enhancing medicines. As a result, international organizations, including the World Health Organization and the World Bank are beginning to address the issue of corruption in the health sector broadly and the pharmaceutical system specifically. This is encouraging news for improving drug access for the global poor who are most harmed by corruption as they tend to purchase less expensive drugs from unqualified or illegal drug sellers selling counterfeit or sub-standard drugs. In our paper, we illuminate what are the core issues that relate to corruption in the pharmaceutical sector. We argue that corruption in the pharmaceutical system can be detrimental to a country's ability to improve the health of its population. Moreover, unless policy makers deal with the issue of corruption, funding allocated to the pharmaceutical system to treat health conditions may simply be wasted and the inequality between rich and poor in access to health and pharmaceutical products will be aggravated.
Assuntos
Indústria Farmacêutica/normas , Política Pública , Documentação , Custos de Medicamentos , Indústria Farmacêutica/legislação & jurisprudência , Prescrições de Medicamentos/normas , Fraude , Legislação de Medicamentos , Farmácias/normasRESUMO
Apolipoprotein(a) [apo(a)], an apolipoprotein unique to lipoprotein(a) [Lp(a)], is highly polymorphic in size. Previous studies have indicated that the size of the apo(a) gene tends to be inversely correlated with the plasma level of Lp(a). However, several exceptions to this general trend have been identified. Individuals with apo(a) alleles of identical size do not always have similar plasma concentrations of Lp(a). To determine if these differences in plasma Lp(a) concentrations were due to sequence variations in the apo(a) gene, we examined the sequences of apo(a) alleles in 23 individuals homozygous for same-sized apo(a) alleles. We identified four single-strand DNA conformation polymorphisms (SSCPs) in the apo(a) gene. Of the 23 homozygotes, 21 (91%) were heterozygous for at least one of the SSCPs. Analysis of a family in which a parent was homozygous for the same-sized apo(a) allele revealed that each allele, though identical size, segregated with different plasma concentrations of Lp(a). These studies indicate that the apo(a) gene is even more polymorphic in sequence than was previously appreciated, and that sequence variations at the apo(a) locus, other than the number of kringle 4 repeats, contribute to the plasma concentration of Lp(a).
Assuntos
Apolipoproteínas A/genética , Lipoproteína(a)/sangue , Alelos , Animais , Sequência de Bases , DNA de Cadeia Simples/química , Feminino , Genótipo , Humanos , Masculino , Dados de Sequência Molecular , Conformação de Ácido Nucleico , Linhagem , Polimorfismo GenéticoRESUMO
Genetic factors have been shown to play an important role in determining interindividual variation in plasma HDL-C levels, but the specific genetic determinants of HDL cholesterol (HDL-C) levels have not been elucidated. In this study, the effects of variation in the genomic regions encoding hepatic lipase, apolipoprotein AI/CIII/AIV, and the cholesteryl ester transfer protein on plasma HDL-C levels were examined in 73 normotriglyceridemic, Caucasian nuclear families. Genetic factors accounted for 56.5 +/- 13% of the interindividual variation in plasma HDL-C levels. For each candidate gene, adjusted plasma HDL-C levels of sibling pairs who shared zero, one, or two parental alleles identical-by-descent were compared using sibling-pair linkage analysis. Allelic variation in the genes encoding hepatic lipase and apolipoprotein AI/CIII/AIV accounted for 25 and 22%, respectively, of the total interindividual variation in plasma HDL-C levels. In contrast, none of the variation in plasma HDL-C levels could be accounted for by allelic variation in the cholesteryl ester transfer protein. These findings indicate that a major fraction of the genetically determined variation in plasma HDL-C levels is conferred by allelic variation at the hepatic lipase and the apolipoprotein AI/CIII/AIV gene loci.
Assuntos
Apolipoproteínas/genética , HDL-Colesterol/sangue , Variação Genética , Lipase/genética , Fígado/enzimologia , Apolipoproteína A-I/genética , Apolipoproteína C-III , Apolipoproteínas A/genética , Apolipoproteínas C/genética , Sequência de Bases , Causalidade , Humanos , Dados de Sequência Molecular , Núcleo Familiar , Estatística como Assunto/métodosRESUMO
Distributions of plasma lipoprotein(a) (Lp[a]) concentrations exhibit marked interracial differences. Apolipoprotein(a) (apo[a]), the unique constituent of Lp(a), is highly polymorphic in length due to allelic variations in the number of kringle 4(K-4)-encoding sequences. Plasma Lp(a) concentrations are inversely related to the number of K-4 repeats in the apo(a) alleles. To determine the contribution of this length variation to the interracial variation in plasma Lp(a) levels, we compared apo(a) allele size, glycoprotein size, and plasma Lp(a) concentrations in Caucasians, Chinese, and African Americans. Caucasians and African Americans had very different distributions of plasma Lp(a) concentrations yet there was no significant difference in the overall frequency distributions of their apo(a) alleles. Over the entire size spectrum of apo(a) alleles, the plasma Lp(a) levels were higher in African Americans than in Caucasians. Conversely, Caucasians and Chinese had similar plasma Lp(a) concentrations but significantly different apo(a) allele size distributions. Therefore, interracial differences in the plasma concentrations of Lp(a) are not due to differences in the frequency distributions of apo(a) alleles. We also examined the relationship between apo(a) allele size and the presence of detectable plasma apo(a) protein in plasma. Apo(a) alleles associated with no detectable plasma protein were not of uniformly large size, as had been expected, but were distributed over the entire size spectrum. From this analysis, we conclude that there is no common "null" allele at the apo(a) locus.
Assuntos
Alelos , Apolipoproteínas/genética , Glicoproteínas/sangue , Lipoproteína(a)/sangue , Apoproteína(a) , Povo Asiático/genética , População Negra/genética , China , Mapeamento Cromossômico , Feminino , Humanos , Masculino , População Branca/genéticaRESUMO
The retinyl palmitate fat tolerance test was used to measure chylomicron remnant clearance in 10 normal subjects (apolipoprotein E [apo E] isotypes 3 or 4 only), 6 normolipidemic apo E2/2 homozygotes and 5 familial hypercholesterolemic homozygotes. Skin fibroblasts with fully upregulated LDL receptors from the latter subjects degraded rabbit 125I-beta VLDL in vitro at rates ranging from less than 10-48% of normal. Experiments in vivo revealed no significant differences between the normal and homozygous familial hypercholesterolemic (FHH) subjects in chylomicron remnant clearance assessed on the basis of "areas under the curves" for retinyl palmitate levels present in post-prandial serum, chylomicron remnants (Sf. less than 1,000), or chylomicrons (Sf. greater than 1,000). Remnant clearance was greatly decreased at all times in the apo E2/2 homozygotes, indicative of an important degree of flux control exerted by a receptor-mediated step involving apo E as ligand. The absence of any excess remnant accumulation in FHH subjects with varying "impairment" of LDL receptor-mediated degradation of apo E-containing lipoproteins, permits the conclusion that chylomicron remnants are initially cleared from the plasma by apo E-recognizing receptors which are genetically distinct from LDL receptors.
Assuntos
Quilomícrons/metabolismo , Hiperlipoproteinemia Tipo II/metabolismo , Receptores de LDL/fisiologia , Adolescente , Adulto , Células Cultivadas , Diterpenos , Feminino , Homozigoto , Humanos , Lipoproteínas LDL/metabolismo , Lipoproteínas VLDL/metabolismo , Masculino , Taxa de Depuração Metabólica , Ésteres de Retinil , Vitamina A/análogos & derivados , Vitamina A/metabolismoRESUMO
Interindividual differences in plasma low-density lipoprotein cholesterol (LDL-C) levels reflect both environmental variation and genetic polymorphism, but the specific genes involved and their relative contributions to the variance in LDL-C are not known. In this study we investigated the relationship between plasma LDL-C concentrations and three genes with pivotal roles in LDL metabolism: the low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), and cholesterol 7alpha-hydroxylase (CYP7). Analysis of 150 nuclear families indicated statistically significant linkage between plasma LDL-C concentrations and CYP7, but not LDLR or APOB. Further sibling pair analyses using individuals with high plasma LDL-C concentrations as probands indicated that the CYP7 locus was linked to high plasma LDL-C, but not to low plasma LDL-C concentrations. This finding was replicated in an independent sample. DNA sequencing revealed two linked polymorphisms in the 5' flanking region of CYP7. The allele defined by these polymorphisms was associated with increased plasma LDL-C concentrations, both in sibling pairs and in unrelated individuals. Taken together, these findings indicate that polymorphism in CYP7 contributes to heritable variation in plasma LDL-C concentrations. Common polymorphisms in LDLR and APOB account for little of the heritable variation in plasma LDL-C concentrations in the general population.
Assuntos
Apolipoproteínas B/genética , Colesterol 7-alfa-Hidroxilase/genética , LDL-Colesterol/genética , LDL-Colesterol/metabolismo , Receptores de LDL/genética , Adulto , Alelos , Apolipoproteínas B/sangue , Apolipoproteínas B/metabolismo , Apolipoproteínas E/sangue , Apolipoproteínas E/genética , Apolipoproteínas E/metabolismo , Colesterol/sangue , Colesterol 7-alfa-Hidroxilase/metabolismo , LDL-Colesterol/sangue , DNA/análise , DNA/genética , Feminino , Ligação Genética , Humanos , Lipoproteínas/sangue , Masculino , Pessoa de Meia-Idade , Linhagem , Reação em Cadeia da Polimerase , Polimorfismo Genético , Receptores de LDL/metabolismo , Análise de Sequência de DNA , Triglicerídeos/sangueRESUMO
The transcriptional activities of the eleven mouse mammary tumor virus (MMTV) proviruses endogenous to two sets of recombinant inbred (RI) mouse strains, BXD and BXH, were characterized. Comparison of the levels of virus-specific RNA quantitated in each strain showed no direct relationship between the presence of a particular endogenous provirus or with increasing numbers of proviruses. Association of specific genetic markers with the level of MMTV-specific RNA was examined by using multiple regression analysis. Several cellular loci as well as proviral loci were identified that were significantly associated with viral expression. Importantly, these cellular loci associated with MMTV expression segregated independently of viral sequences.
Assuntos
Vírus do Tumor Mamário do Camundongo/genética , Oncogenes , Transcrição Gênica , Alelos , Animais , Transformação Celular Neoplásica , Feminino , Genes Virais , Lipopolissacarídeos/farmacologia , Vírus do Tumor Mamário do Camundongo/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos , Hibridização de Ácido Nucleico , RNA Viral/genética , RNA Viral/isolamento & purificação , Especificidade da EspécieRESUMO
There are acute disparities in pharmaceutical access between developing and industrialized countries. Developing countries make up approximately 80% of the world's population but only represent approximately 20% of global pharmaceutical consumption. Among the many barriers to drug access are the potential consequences of the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement. Many developing countries have recently modified their patent laws to conform to the TRIPS standards, given the 2005 deadline for developing countries. Safeguards to protect public health have been incorporated into the TRIPS Agreement; however, in practice governments may be reluctant to exercise such rights given concern about the international trade and political ramifications. The Doha Declaration and the recent Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health may provide more freedom for developing countries in using these safeguards. This paper focuses on Ghana, a developing country that recently changed its patent laws to conform to TRIPS standards. We examine Ghana's patent law changes in the context of the Doha Declaration and assess their meaning for access to drugs of its population. We discuss new and existing barriers, as well as possible solutions, to provide policy-makers with lessons learned from the Ghanaian experience.
RESUMO
BACKGROUND: Numerous clinical conditions have been proposed to explain the premature onset of symptomatic peripheral vascular disease (PVD) in young adults, but the role of genetic factors has not been defined. This study was performed to determine the prevalence of cardiovascular disease among family members of patients with premature PVD. METHODS: The prevalence of early cardiovascular events occurring in first-degree relatives of 90 subjects with premature PVD (onset < or =49 years) was determined. The prevalence of occult atherosclerosis was determined by duplex ultrasonography in a cohort of 20 asymptomatic siblings. Reference groups included first-degree relatives of 80 subjects with premature coronary artery disease (CAD) and first-degree relatives of 48 healthy subjects. RESULTS: Cardiovascular events occurred at age 55 years or younger in 28% of the parents of PVD subjects, in 23% of parents of CAD subjects, and in 7% of the parents of healthy controls (P<.001). Cardiovascular events occurred in 24% of siblings of PVD subjects, in 14% of siblings of CAD subjects, and in 7% of siblings of healthy controls (P<.001). Duplex ultrasonography detected early plaques in the lower extremity circulation of 10 (50%) of the asymptomatic siblings of PVD subjects. CONCLUSIONS: Early, symptomatic cardiovascular disease is more common in first-degree relatives of individuals with premature PVD than in relatives of healthy individuals or of probands with premature CAD. Occult vascular disease in the lower extremity is prevalent among asymptomatic siblings of probands with premature PVD. These observations indicate that susceptibility to premature PVD has a familial basis.
Assuntos
Idade de Início , Arteriosclerose/epidemiologia , Arteriosclerose/genética , Doenças Cardiovasculares/epidemiologia , Adulto , Feminino , Predisposição Genética para Doença , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Sitosterolemia is an autosomal recessive disorder caused by mutations in two adjacent genes encoding coordinately regulated ATP binding cassette (ABC) half transporters (ABCG5 and ABCG8). In this paper we describe three novel mutations causing sitosterolemia: 1) a frameshift mutation (c.336-337insA) in ABCG5 that results in premature termination of the protein at amino acid 197; 2) a missense mutation that changes a conserved residue c.1311C>G; N437K) in ABCG5 and 3) a splice site mutation in ABCG8 (IVS1-2A>G). This study expands the spectrum of the ABCG5 and ABCG8 mutations that cause sitosterolemia. Nine nonsynonymous polymorphisms are also reported: I523V, C600Y, Q604E, and M622V in ABCG5; and D19H, Y54C, T400K, A632V, and Y641F in ABCG8.
Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Erros Inatos do Metabolismo Lipídico/sangue , Erros Inatos do Metabolismo Lipídico/genética , Lipoproteínas/genética , Mutação/genética , Sitosteroides/sangue , Membro 5 da Subfamília G de Transportadores de Cassetes de Ligação de ATP , Membro 8 da Subfamília G de Transportadores de Cassetes de Ligação de ATP , Colesterol/sangue , Análise Mutacional de DNA , Éxons/genética , Feminino , Frequência do Gene/genética , Humanos , Íntrons/genética , Masculino , Polimorfismo Genético/genética , Sítios de Splice de RNA/genética , População Branca/genéticaRESUMO
To examine the effects of anabolic steroid use on glucose homeostasis, we determined oral glucose tolerance and serum insulin response to glucose in 15 male powerlifters, 6 obese men, and 10 sedentary nonobese men. Eight of the powerlifters had self-administered large doses (200 mg/day) of anabolic steroids for periods of up to 7 yr, whereas 7 had never used anabolic steroids. Powerlifters who ingested anabolic steroids had diminished glucose tolerance compared to the nonsteroid-using group, despite having substantially higher postglucose serum insulin concentrations. Postglucose insulin responses were also higher in steroid users than in the sedentary nonobese and sedentary obese reference groups. These results indicate that powerlifters who ingest anabolic steroids have diminished glucose tolerance, which is likely to be secondary to insulin resistance.
Assuntos
Anabolizantes/efeitos adversos , Teste de Tolerância a Glucose , Resistência à Insulina , Esportes , Levantamento de Peso , Adulto , Glicemia/metabolismo , Peso Corporal , Humanos , Insulina/sangue , Masculino , Obesidade/sangueRESUMO
Three indirect methods for assessing chylomicron-triglyceride clearance were compared in 12 normolipidemic men. Oral and intravenous fat tolerance tests and a duodenal fat perfusion were performed in each subject by standard methods. Mean values for postprandial lipemia (2.27 +/- 1.8 mmol), Intralipid half-life (13.7 +/- 5.2 min), and chylomicron-triglyceride half-life (4.5 +/- 2.6 min) were similar to corresponding values reported previously for normolipidemic men. The sample correlation coefficient (r) was 0.84 between oral and intravenous fat-tolerance tests, 0.84 between the oral fat-tolerance test and the duodenal-perfusion method, and 0.82 between the intravenous fat-tolerance and the duodenal perfusion methods. All three methods showed a strong correlation between chylomicron-triglyceride clearance and fasting triglyceride concentrations. These findings indicate that the oral and intravenous fat-tolerance tests and the duodenal-perfusion method yield qualitatively similar assessments of chylomicron-triglyceride clearance in normolipidemic men.
Assuntos
Quilomícrons/metabolismo , Triglicerídeos/farmacocinética , Adulto , Gorduras na Dieta/farmacologia , Duodeno , Humanos , Hiperlipidemias/metabolismo , Masculino , Métodos , Perfusão , Valores de Referência , Triglicerídeos/sangueRESUMO
The effects of glucose, sucrose, and fructose ingestion on the serum triglyceride responses to meals containing 40 g fat were studied in 21 normolipidemic, nonobese medical students (9 men, 12 women). Mean postprandial lipemia was not significantly lower after meals containing 50 g glucose and 40 g fat than after meals containing 40 g fat alone (2.11 vs 2.42 mmol.L-1.7 h-1, p greater than 0.45) despite a substantial increase in plasma insulin concentrations after the glucose-containing meal. Ingestion of 50 g fructose and 40 g fat (4.23 mmol.L-1.7 h-1, p less than 0.0001) and 100 g sucrose and 40 g fat (3.77 mmol.L-1.7 h-1, p less than 0.001) resulted in significantly greater lipemia than did the ingestion of fat alone. These findings suggest that the ingestion of insulinogenic carbohydrates does not reduce postprandial lipemia in normolipidemic subjects and that the ingestion of fructose and fructose-containing carbohydrates may augment the postprandial lipemia induced by a fat-containing meal.
Assuntos
Carboidratos da Dieta/farmacologia , Gorduras na Dieta/metabolismo , Triglicerídeos/sangue , Adulto , Feminino , Frutose/administração & dosagem , Glucose/administração & dosagem , Humanos , Insulina/sangue , Masculino , Sacarose/administração & dosagemRESUMO
To determine the dose response of serum triglyceride concentrations to fat feeding, serum triglyceride responses to meals containing 40, 80, and 120 g fat (in the form of dairy cream) were measured in 12 normotriglyceridemic men. Mean postprandial lipemia (measured as the integrated area under the curve of serum triglyceride concentration plotted against time) was 251 +/- 129 mg.dL-1.8 h-1 (2.83 +/- 1.46 mmol.L-1.8 h-1) after the 40-g-fat meal, 503 +/- 233 mg.dL-18 h-1 (5.68 +/- 2.63 mmol.L-1.8 h-1) after the 80-g-fat meal, and 712 +/- 281 mg.dL-1.8 h-1 (8.04 +/- 3.17 mmol.L-1.8 h-1) after the 120-g-fat meal. These data indicate that in normotriglyceridemic men the magnitude of lipemia that follows the ingestion of a fat meal is directly proportional to the fat content of the meal. The results also suggest that the mechanism whereby triglyceride is removed from the intravascular compartment is not saturated by meals containing the amounts of fat typically consumed by men following a Western diet.
Assuntos
Gorduras na Dieta/farmacologia , Triglicerídeos/sangue , Adulto , Laticínios , Relação Dose-Resposta a Droga , Humanos , Masculino , Valores de ReferênciaRESUMO
To examine the effects of exercise on postprandial serum triglyceride (TG) metabolism, we measured oral and intravenous fat tolerance and chylomicron-TG half-life in highly trained endurance athletes and in a sedentary control group matched for body weight and fasting serum TG concentration. Postprandial lipemia was lower in athletes after meals containing 40 g fat (1.5 +/- 0.7 vs 2.6 +/- 1.5 mmol.L-1.8 h-1, p less than 0.001) or 140 g fat (2.5 +/- 1.2 vs 6.1 +/- 1.9 mmol.L-1.8 h-1, p less than 0.001). The disappearance of an intravenous bolus of Intralipid was faster in athletes (5.4 +/- 1.2%/min) than in sedentary men (4.3 +/- 0.8%/min, p less than 0.01). The half-life of chylomicron-TG was shorter in athletes (3.0 +/- 0.8 min) than in sedentary men (4.0 +/- 1.0 min, p less than 0.05). These findings indicate that chronic exercise decreases postprandial lipemia by reducing chylomicron-TG's half-life. This effect is due partly to reduced fasting serum TG pool size and partly to a direct effect of exercise on the serum TG removal system.
Assuntos
Quilomícrons/sangue , Ingestão de Alimentos , Exercício Físico , Triglicerídeos/sangue , Adulto , Humanos , MasculinoRESUMO
The gene frequencies of a polymorphism in the 5'-flanking region of the insulin gene and its relationship to cardiovascular disease risk were studied in a well defined population of children (mean age 5.5 years) from a biracial community. The BglII endonuclease was used for digestion of the DNA around this polymorphic region. The risk factors studied included parental and grandparental self-reported histories of myocardial infarction and diabetes mellitus, fasting glucose and insulin levels, lipoprotein, cholesterol, and triglyceride levels, and skinfold thicknesses and weight. Four alleles were observed at this locus, with the class 2 allele being significantly more common among blacks than whites. Among white children, the class 3 allele was associated with increased risk for grandparental diabetes mellitus. White children with 2 copies of the class 3 allele had significantly higher levels of glucose. Black children with a copy of the class 3 allele had significantly higher levels of insulin. This study indicates that the class 3 allele is potentially associated with risk for diabetes mellitus and coronary heart disease that can be observed in childhood.